Mergers & Acquisitions
Siemens sells clinical microbiology biz to Beckman Coulter
Medtronic fights tax dodging rhetoric in Covidien merger
Could Medtronic-Covidien deal get caught in anti-inversion legislation?
Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere
The world’s largest medical device operation is eyeing acquisitions to bolster its "subscale" cardiovascular business, particularly its electrophysiology business, Johnson & Johnson (NYSE:JNJ) chairman & CEO Alex Gorsky told analysts yesterday.
Covidien shareholder files class action lawsuit blocking company’s merger with Medtronic | The week in medtech M&A
St. Jude drops $200M on NeuroTherm for spinal pain device
Minnesota-based medtech giant St. Jude Medical (NYSE:STJ) is broaching new ground in the spinal pain market with the $200 million acquisition of NeuroTherm, maker of radiofrequency ablation therapies.